Dr. Jacqueline Lui, President of Eagle IP Limited, gave a talk titled “IP Protection Strategies for Drugs” at the Hong Kong Productivity Council for the forum “如何利用防偽技術保護藥品商標及品牌研討會(II)”.
我们的过去活动
Recommended Insights
Everything you need to know about Patent Term Adjustment (PTA) in China
2024年5月7日We previously discussed patent term compensation for patent office delay (‘Patent Term Adjustment’ or ‘PTA’) when such new system was introduced in the Fourth Amendment of the Chinese Patent Law (2020), as well as in the different versions of the Draft Examination Guidelines released in 2021 and 2022. In this article, we consolidate everything you need to […]
阅读更多 >
The Latest on Post-Filing Data in China’s Patent Law
2020年4月29日Post-filing data can sometimes be the crucial difference between a patent allowance and a final rejection. The reasons are endless why important data may not have been included in the original patent application as filed. Time and budget may have been insufficient to generate data over the full scope of the claims at the time […]
阅读更多 >
China Announcing More Proposed Amendments to the Examination Guidelines in 2022
2022年11月17日It’s been a year and a half since the new Chinese Patent Law came into effect (1 June 2021). Although various versions of draft Examination Guidelines have been released, thus far no official finalized versions have been confirmed. On October 31, 2022, yet another new list of proposed amendments was published1, this time consolidating the […]
阅读更多 >
China Provides Specific Directions to Strengthen Patent / Technology Protection from 2020 to 2021
2020年4月23日China continues to progress towards its major goal of significantly strengthening IP protection within its borders. Last year it announced several proposed amendments to its patent laws. In January 2020 China and the US signed the Economic and Trade Agreement between the Government of China and US (published 16 January 2020 –“Trade Agreement”), which detailed […]
阅读更多 >